Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    November 2027
  1. TUPPER HI, Shrager JB, Moghanaki D, Simone CB 2nd, et al
    Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms-Methodology Matters: A Joint Statement from The Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology.
    Int J Radiat Oncol Biol Phys. 2027 Nov 11:S0360-3016(25)06618.
    >> Share

    May 2026
  2. BOGART JA, Wang X, Masters G, Komaki R, et al
    Brief Report: Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: CALGB 30610 (Alliance) / RTOG 0538.
    Int J Radiat Oncol Biol Phys. 2026 May 3:S0360-3016(26)00688.
    >> Share

  3. CHETTY IJ, Zhong H
    Deformable Dose Mapping and Accumulation Techniques for Stereotactic Body Radiation Therapy (SBRT) of Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2026;125:86-101.
    >> Share

  4. CEDOZ E, Levy A, Martel-Lafay I, Bondiau PY, et al
    Stereotactic Versus Standard Tumor Irradiation in Unresectable Locally Advanced Non-small Cell Lung Cancer With Durvalumab Maintenance: A Multicenter Study With Propensity Score Matching.
    Int J Radiat Oncol Biol Phys. 2026;125:112-122.
    >> Share

  5. BAKER S, Leclerc C, Atmanspacher-Wirth H, Zhao Y, et al
    The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:102-111.
    >> Share

    April 2026
  6. KAO CF, Sheu RJ, Peir JJ, Wu YH, et al
    Development and Application of a Simplified Mathematical Model for The Estimation of Tumor Dose of Non-Small Cell Lung Cancer in BNCT.
    Int J Radiat Oncol Biol Phys. 2026 Apr 21:S0360-3016(26)00596.
    >> Share

  7. LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al
    Erratum to 'Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.' International Journal of Radiation Oncology*Biology*Phy
    Int J Radiat Oncol Biol Phys. 2026 Apr 3:S0360-3016(26)00512.
    >> Share

  8. KARLSSON K, Rancati T, Lindback E, Lindberg S, et al
    Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort.
    Int J Radiat Oncol Biol Phys. 2026;124:1298-1308.
    >> Share

  9. FUCHS F, Herrera R, Kotecha R, Rubens M, et al
    Multi-institutional Analysis of MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy: Feasibility, Safety, and Efficacy.
    Int J Radiat Oncol Biol Phys. 2026;124:1421-1430.
    >> Share

  10. ABI JAOUDE J, Cui S, Fu J, Worth JE, et al
    Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial.
    Int J Radiat Oncol Biol Phys. 2026;124:1309-1317.
    >> Share

  11. SALUNKHE R, Palma DA, Warner A, Bahig H, et al
    Dosimetric Outcomes of Stereotactic Body Radiation Therapy to Ultracentral Lung Tumors: Lessons From the SUNSET Trial.
    Int J Radiat Oncol Biol Phys. 2026;124:1290-1297.
    >> Share

    March 2026
  12. ADIB E, Willers H, Samson PP, Robinson CG, et al
    Integration of Immune Checkpoint Blockade With Radiation in Lung Cancer: Lessons From Recent Trials.
    Int J Radiat Oncol Biol Phys. 2026;124:887-891.
    >> Share

  13. ZRAFI WS, Albarran-Artahona V, Dall'Olio FG, Ghigna MR, et al
    Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trial.
    Int J Radiat Oncol Biol Phys. 2026 Mar 13:S0360-3016(26)00491.
    >> Share

  14. SINGH AK, Farrugia MK, Stephans KL, Bogart JA, et al
    Long-term Analysis of One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2026 Mar 13:S0360-3016(26)00487.
    >> Share

  15. ITO S, Nakajima Y, Fujita Y, Capaldi DPI, et al
    Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized (3)He Magnetic Resonance Imaging in Patients with Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026 Mar 7:S0360-3016(26)00480.
    >> Share

    February 2026
  16. BARRETT S, Zahid M, McGarry CK, Enderling H, et al
    External Validation of The Proliferation Saturation Index Model in Predicting Tumour Volume Regression in Patients with Non-Small Cell Lung Cancer Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 20:S0360-3016(26)00399.
    >> Share

  17. REUTER LM, Kraus KM, Fischer SM, Pletzer D, et al
    Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE trials.
    Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00365.
    >> Share

  18. LIN CS, Shen C, Banks T, Prasad R, et al
    Feasibility, Workflow, Dosimetry and PET Signal Trends in Lung Cancer Treated with Biology-Guided Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 4:S0360-3016(25)06621.
    >> Share

  19. WIMMERT L, Gauer T, Dickmann J, Hofmann C, et al
    Dose Reduction in 4-Dimensional Computed Tomography Imaging: Breathing Signal-Guided Deep Learning-Driven Data Acquisition.
    Int J Radiat Oncol Biol Phys. 2026;124:512-521.
    >> Share

  20. SAID BI, Boukhaled GM, Lok BH, Lukovic J, et al
    Cross-Cancer Analysis Reveals a Distinct Pattern of Immune Modulation During Curative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026;124:441-450.
    >> Share

    January 2026
  21. ZHAI T, Toprani SM, Dillon-Martin M, Doyle PF, et al
    Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Jan 14:S0360-3016(26)00064.
    >> Share

  22. SIMONE CB 2ND
    A Potential Path Toward Finally Improving Outcomes With Concurrent Immunotherapy and Chemoradiation for Lung Cancer: Low-Dose Radiation Therapy Lessons From the MATCH Trial in Extensive-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026;124:174-176.
    >> Share

    December 2025
  23. MA J, Yu H, Zhang X, Yuan J, et al
    Skull Dosimetry for Mitigating Acute Hematologic Toxicity in NSCLC Patients with Brain Metastases Undergoing Cranial Radiotherapy and Immunotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Dec 24:S0360-3016(25)06623.
    >> Share

  24. CAMMARERI E, Duijm M, Granton PV, Schillemans W, et al
    High dose REirradiation for in-field recurrent Lung Cancer in the THOrax (RETHO): outcomes of a phase 2 prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2025 Dec 20:S0360-3016(25)06616.
    >> Share

  25. KOTHARI G, O'Byrne KJ, Brown C, Stockler MR, et al
    A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiotherapy (SABR) in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD).
    Int J Radiat Oncol Biol Phys. 2025 Dec 19:S0360-3016(25)06610.
    >> Share

  26. THOMPSON LL, Amin PM, Shah S, Lipson SM, et al
    Associations Between G8 Geriatric Screening Score, Charlson Comorbidity Index, AI-Based Age Phenotype, and Overall Survival in Older Adults With Stage I-II Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:1295-1305.
    >> Share

    November 2025
  27. HOU Q, Parpia S, Wierzbicki M, Kundapur V, et al
    Quality of Life of Stereotactic vs. Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results from the XXXXXX trial.
    Int J Radiat Oncol Biol Phys. 2025 Nov 21:S0360-3016(25)06498.
    >> Share

  28. LI GJ, Soon MS, Chen H, Boldt G, et al
    Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric Analysis.
    Int J Radiat Oncol Biol Phys. 2025;123:1050-1060.
    >> Share

  29. AVERBUCH I, Appel S, Blumenfeld P, Goltser A, et al
    Assessment of the Effective Dose to Immune Cells as an Independent predictor of Durvalumab response in Non-Small Cell Lung Cancer patients after Chemoradiotherapy: A Multi-Center Study.
    Int J Radiat Oncol Biol Phys. 2025 Nov 14:S0360-3016(25)06478.
    >> Share

    October 2025
  30. CHEN X, Zhang X, Xu T, Mohan R, et al
    Radiation doses to cardiac substructures predict elevation in high-sensitivity cardiac troponin T (hs-cTnT) levels in radiotherapy for lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Oct 17:S0360-3016(25)06388.
    >> Share

  31. ZHAN TY, Zhang T, Wang WQ, Deng L, et al
    Simultaneous Integrated Dose Reduction Radiotherapy Versus Conventional Fractionated Radiotherapy With Chemotherapy for Limited-Stage Small-Cell Lung Cancer in the Modern Treatment Era: a Phase III, Randomized Clinical Trial (SDR-RT trial).
    Int J Radiat Oncol Biol Phys. 2025 Oct 14:S0360-3016(25)06331.
    >> Share

  32. MORRIS T, Muradova Z, Brown N, Carmes L, et al
    Second-Generation Gadolinium-Bismuth Ultrasmall Nanoparticles Amplify the Effects of Clinical Radiation Therapy and Provide Clinical Magnetic Resonance Imaging Contrast.
    Int J Radiat Oncol Biol Phys. 2025;123:572-582.
    >> Share

  33. TOM MC, Wang K, Edwards DM, Huang J, et al
    Electrifying Results? Tumor Treating Fields Reduce Intracranial Relapse of Non-Small Cell Lung Cancer Brain Metastasis Following Radiosurgery in the METIS Trial.
    Int J Radiat Oncol Biol Phys. 2025 Oct 1:S0360-3016(25)06224.
    >> Share

    September 2025
  34. MEHTA MP, Gondi V, Ahluwalia MS, Roberge D, et al
    Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06217.
    >> Share

  35. DANG A, Palma DA, Wang E, Lang P, et al
    Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06288.
    >> Share

  36. LI Q, Ma H, Zheng R, Cai L, et al
    Durvalumab combined with chemotherapy and Stereotactic Ablative Body Radiotherapy (SABR) in patients with oligometastatic non-small cell lung cancer: a multi-center phase 2 study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 24:S0360-3016(25)06304.
    >> Share

  37. ARCIDIACONO F, Anselmo P, Casale M, Zannori C, et al
    5-year survival and safety of stereotactic ablative radiotherapy in unresectable locally advanced non-small cell lung cancer patients unfit for concurrent radio-chemotherapy:focus on patterns of local recurrence from the START-NEW-ERA non-randomized p
    Int J Radiat Oncol Biol Phys. 2025 Sep 22:S0360-3016(25)06209.
    >> Share

  38. FRIEDES C, Yegya-Raman N, Iocolano M, Levin WP, et al
    Primary Tumor Failure after Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Brief Report on the Implications for NRG LU-008.
    Int J Radiat Oncol Biol Phys. 2025 Sep 16:S0360-3016(25)06276.
    >> Share

  39. RUTKOWSKI J, Nowicka Z, Sobocki BK, Slebioda T, et al
    Patterns of immunity changes predict response to stereotactic ablative radiotherapy in early non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 3:S0360-3016(25)06206.
    >> Share

    August 2025
  40. WANG W, Ren M, Ren J, Dang J, et al
    Predicting Radiation Pneumonitis Integrating Clinical Information, Medical Text, and 2.5D Deep Learning Features in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06035.
    >> Share

  41. GEWIRTZ A, Yang JT
    Leptomeningeal Spread in EGFR-Mutant Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1086-1087.
    >> Share

  42. ROGAWSKI D, Nagpal S
    Hold Your Fire: The Case for Targeted Therapy, Not Radiation, for EGFR-mutant Non-small Cell Lung Cancer Leptomeningeal Disease.
    Int J Radiat Oncol Biol Phys. 2025;122:1084.
    >> Share

  43. GAL O, Kotecha R
    Leptomeningeal Spread in EGFR Mutation Non-Small Cell Lung Cancer: No More One Size Fits All.
    Int J Radiat Oncol Biol Phys. 2025;122:1084-1086.
    >> Share

  44. HAISRAELY O, Tom MC
    Beneath the Surface: Peeling Back Layers of Management Complexity for Leptomeningeal Disease From EGFR-mutant Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1082-1083.
    >> Share

    July 2025
  45. MONTI S, Giuseppe P, Caroprese M, Cella L, et al
    External Validation of Dose Patterns and Dosimetric Predictors for Radiation-Induced Esophagitis in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06043.
    >> Share

  46. MAURY P, Sayous Y, Marnaoui R, Loiseau C, et al
    Stereotactic Ablative Radiotherapy (SABR) Quality and Survival of Patients with Head and Neck Cancer: a post-hoc analysis of the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025 Jul 24:S0360-3016(25)06019.
    >> Share

  47. LIU Y, Ma N, Li Y, Fan X, et al
    Relative Biological Effectiveness Derived from NTCP Analysis of Carbon Ion vs. Photon Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 21:S0360-3016(25)06016.
    >> Share

  48. SAMSON P, Robinson C
    How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:785.
    >> Share

  49. MEYER S, Hu YC, Rimner A, Mechalakos J, et al
    Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:818-826.
    >> Share

  50. CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:957-967.
    >> Share

  51. CORN BW, Paulus R, Gondi V, Mehta MP, et al
    "Hope" Drives Quality of Life in Patients with Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003.
    Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04519.
    >> Share

  52. AKDEMIR EY, Herrera R, Gurdikyan S, Hodgson LC, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm.
    Int J Radiat Oncol Biol Phys. 2025;122:739-751.
    >> Share

  53. ZHOU L, Sun J, Xie C, Kang K, et al
    Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH).
    Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508.
    >> Share

    June 2025
  54. ZHANG SC, Kehayias CE, Guthier C, He J, et al
    Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493.
    >> Share

  55. DUAN J, Zhu Y, Jiang W, Wang W, et al
    Risk-Based Local Radiation Therapy in Oligometastatic Non-small Cell Lung Cancer in the Era of Immunotherapy: A Multicentric Cohort Study.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04499.
    >> Share

  56. ZHANG Y, Laine AM, Iyengar P, Westover KD, et al
    Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:374-382.
    >> Share

  57. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
    Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).
    Int J Radiat Oncol Biol Phys. 2025;122:365-373.
    >> Share

    May 2025
  58. KNOTH J, Nout RA, Potter R, Mahantshetty DU, et al
    Distant metastasis after chemoradiation and IGABT in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
    >> Share

  59. KEANE F, Daly M, Louie A, Harris J, et al
    Resistance is Futile: Stereotactic Body Radiation Therapy for Oligoprogressive Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1-4.
    >> Share

    April 2025
  60. ALFAIFI SA, Louie AV, Siva S, Guckenberger M, et al
    International Patterns of Practice for Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of practice for SABR for early-stage NSCLC.
    Int J Radiat Oncol Biol Phys. 2025 Apr 29:S0360-3016(25)00390.
    >> Share

  61. SIMONE CB 2ND, Amini A, Chetty IJ, Choi JI, et al
    American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer Executive Summary.
    Int J Radiat Oncol Biol Phys. 2025 Apr 2:S0360-3016(25)00259.
    >> Share

  62. PAN S, Chang CW, Tian Z, Wang T, et al
    Data-Driven Volumetric Computed Tomography Image Generation From Surface Structures Using a Patient-Specific Deep Leaning Model.
    Int J Radiat Oncol Biol Phys. 2025;121:1349-1360.
    >> Share

  63. HUANG YH, Li Z, Xiong T, Chen Z, et al
    Constructing Surrogate Lung Ventilation Maps From 4-Dimensional Computed Tomography-Derived Subregional Respiratory Dynamics.
    Int J Radiat Oncol Biol Phys. 2025;121:1328-1338.
    >> Share

    March 2025
  64. COOKE SA, Belderbos JSA, Stam B, Reymen B, et al
    Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 28:S0360-3016(25)00228.
    >> Share

  65. MONTALVO SK, Lue B, Kakadiaris E, Ahn C, et al
    Global Longitudinal Strain: A Potential Non-invasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Lung Cancer Patients Receiving Thoracic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025 Mar 27:S0360-3016(25)00257.
    >> Share

  66. CHEN X, Meng F, Zhang P, Wang L, et al
    Establishing a deep learning model that integrates pre- and mid-treatment computed tomography to predict treatment response for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00243.
    >> Share

  67. ALLEN SG, Schonewolf CA, Schipper MJ, Yin HM, et al
    Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality Collaborative.
    Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00236.
    >> Share

  68. RIMNER A, Dejonckheere CS, Sahlmann J, Barth SA, et al
    Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 5:S0360-3016(25)00196.
    >> Share

  69. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    >> Share

    February 2025
  70. XIAO L, Li Y, Wang S, Fan L, et al
    Early prediction of radiation pneumonitis in patients with lung cancer treated with immunotherapy through monitoring of plasma chemokines.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00151.
    >> Share

  71. GAETA B, Eichholz JE, Walch H, Ilica AT, et al
    Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with SRS.
    Int J Radiat Oncol Biol Phys. 2025 Feb 8:S0360-3016(25)00093.
    >> Share

  72. MA N, Ming X, Chen J, Jiang GL, et al
    Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
    Int J Radiat Oncol Biol Phys. 2025 Feb 5:S0360-3016(25)00094.
    >> Share

  73. SHIN YS, Yun JK, Jung J, Park JH, et al
    Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:432-441.
    >> Share

    January 2025
  74. LATIFI A, Roumeliotis M, Quirk S, Gardner UG, et al
    Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot.
    Int J Radiat Oncol Biol Phys. 2025 Jan 25:S0360-3016(25)00078.
    >> Share

  75. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    >> Share

  76. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    >> Share

  77. WANG E, Abdallah H, Snir J, Chong J, et al
    Predicting the 3-Dimensional Dose Distribution of Multilesion Lung Stereotactic Ablative Radiation Therapy With Generative Adversarial Networks.
    Int J Radiat Oncol Biol Phys. 2025;121:250-260.
    >> Share

  78. WANG Y, Dong X, Yan S, Liu B, et al
    Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer: A Propensity Score Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:45-55.
    >> Share

    December 2024
  79. BARRETT S, Zahid MU, Enderling H, Marignol L, et al
    Predicting Individual Tumor Response Dynamics in Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy: A Mathematical Modelling Study.
    Int J Radiat Oncol Biol Phys. 2024 Dec 3:S0360-3016(24)03563.
    >> Share

    November 2024
  80. KEANE FK, Yeap BY, Khandekar MJ, Lin JJ, et al
    Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors.
    Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515.
    >> Share

  81. DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al
    Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
    >> Share

  82. ZHAO X, Huang S, Lin H, Choi JI, et al
    A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil Beam Scanning FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;120:1181-1191.
    >> Share

  83. SIMONE CB 2ND
    Enhancing Outcomes in Locally Advanced Non-Small Cell Lung Cancer Through Stereotactic Dose Escalation.
    Int J Radiat Oncol Biol Phys. 2024;120:695-697.
    >> Share

  84. SAMSON P, Harris JP
    Here Comes the Sun: Continuing to Refine the Treatment of Ultracentral Non-Small Cell Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:678-680.
    >> Share

  85. ZHANG S, Simard M, Lapointe A, Filion E, et al
    Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived From Dual-Energy Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;120:894-903.
    >> Share

    October 2024
  86. WEISMAN M, Durm G, Shields MD, Hanna NH, et al
    Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NSCLC): Big Ten
    Int J Radiat Oncol Biol Phys. 2024 Oct 25:S0360-3016(24)03450.
    >> Share

  87. SADDOUGHI SA, Kern R
    Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can All Have a Piece of the Pie.
    Int J Radiat Oncol Biol Phys. 2024;120:357-358.
    >> Share

  88. MCCALL NS, Higgins KA
    Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:343-344.
    >> Share

  89. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
    Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:309-314.
    >> Share

  90. LI GJ, Tan H, Nusrat H, Chang J, et al
    Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
    Int J Radiat Oncol Biol Phys. 2024;120:359-369.
    >> Share

  91. KAMTAM DN, Binkley MS, Kapula N, Sadeghi C, et al
    First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
    Int J Radiat Oncol Biol Phys. 2024;120:345-356.
    >> Share

    September 2024
  92. IGARASHI A, Onishi H, Shioyama Y, Matsumoto Y, et al
    Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan.
    Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174.
    >> Share

  93. GENSHEIMER MF, Kotha NV, Vitzthum LK, Chin AL, et al
    A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410.
    >> Share

  94. MACMANUS MP, Prins E, Xie J, Akhurst T, et al
    Dose-response relationships between radiation exposure, bone marrow function as measured by (18)F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 2:S0360-3016(24)03290.
    >> Share

  95. RANKINE LJ, Lu J, Wang Z, Kelsey CR, et al
    Quantifying Regional Radiation-Induced Lung Injury in Patients Using Hyperpolarized (129)Xe Gas Exchange Magnetic Resonance Imaging.
    Int J Radiat Oncol Biol Phys. 2024;120:216-228.
    >> Share

    August 2024
  96. ZHANG Y, Iyengar P, Montalvo S, Westover KD, et al
    Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03177.
    >> Share

  97. TAN VS, Correa RJM, Nguyen TK, Louie AV, et al
    Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173.
    >> Share

  98. GRONBERG BH
    Are We Finally Ready to Implement Twice-Daily Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2024;119:1391-1392.
    >> Share

  99. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
    Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
    >> Share

  100. PORTIER L, Daira P, Fourmaux B, Heinrich S, et al
    Differential Remodeling of the Oxylipin Pool After FLASH Versus Conventional Dose-Rate Irradiation In Vitro and In Vivo.
    Int J Radiat Oncol Biol Phys. 2024;119:1481-1492.
    >> Share

    July 2024
  101. HARRIS JP, Samson P, Owen D, Siva S, et al
    Adapt or Perish: Adaptive RT for NSCLC.
    Int J Radiat Oncol Biol Phys. 2024;119:1047-1051.
    >> Share

  102. LIU W, Feng H, Taylor PA, Kang M, et al
    NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies.
    Int J Radiat Oncol Biol Phys. 2024;119:1208-1221.
    >> Share

  103. EDWARDS DM, Schonewolf CA, Rice JD, Schipper M, et al
    Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749.
    >> Share


  104. Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J Radiat Oncol Biol Phys 2020;108(3):758-769.
    Int J Radiat Oncol Biol Phys. 2024;119:1030-1031.
    >> Share


  105. Erratum to: Simone CB 2nd, Serebrenik AA, Gore EM, et al. Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Ph
    Int J Radiat Oncol Biol Phys. 2024;119:1029.
    >> Share

  106. HARRISON N, Kang M, Liu R, Charyyev S, et al
    A Novel Inverse Algorithm To Solve the Integrated Optimization of Dose, Dose Rate, and Linear Energy Transfer of Proton FLASH Therapy With Sparse Filters.
    Int J Radiat Oncol Biol Phys. 2024;119:957-967.
    >> Share

    June 2024
  107. NI J, Chen H, Yu L, Guo T, et al
    Predicting regional recurrence and prognosis in stereotactic body radiotherapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00743.
    >> Share

  108. CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al
    Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:640-654.
    >> Share

    May 2024
  109. LEE HI, Choi EK, Kim SS, Shin YS, et al
    Local Ablative Therapy Combined with Pembrolizumab in Patients with Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis.
    Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00674.
    >> Share

    April 2024
  110. MIDRONI J, Salunkhe R, Liu Z, Chow R, et al
    Incorporating functional lung imaging (FLI) into radiation therapy planning in patients with lung cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00481.
    >> Share

  111. ZHANG Q, Fan S, Xu X, Du S, et al
    Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy with Helical TomoTherapy versus Conventional Radiotherapy in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicentre, Randomized
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00450.
    >> Share

  112. MEREDITH EG, Filion E, Faria S, Kundapur V, et al
    Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00480.
    >> Share

  113. LOMBARDO J, Castillo E, Castillo R, Miller R, et al
    Prospective trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00476.
    >> Share

  114. LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al
    Evaluation of radiotherapy treatment plans in a randomized phase II trial comparing two schedules of twice-daily thoracic radiotherapy in limited stage small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00475.
    >> Share

  115. VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al
    BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1172-1180.
    >> Share

  116. HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al
    Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors influencing survival benefit in combination trials.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449.
    >> Share

    March 2024
  117. KIM KH, Kang N, Song SY, Kim HJ, et al
    Safety and efficacy of HL301 in radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving curative concurrent chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled, phase IIa clinical trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447.
    >> Share

  118. FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al
    SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;118:971-978.
    >> Share

  119. LUCIA F, Bourhis D, Pinot F, Hamya M, et al
    Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;118:952-962.
    >> Share

  120. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
    Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
    Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
    >> Share

  121. WALLS GM, Mistry H, Barlesi F, Bezjak A, et al
    Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer: a brief report from the CONVERT trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 11:S0360-3016(24)00382.
    >> Share

  122. YAN W, Ren Z, Chen X, Zhang R, et al
    Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiotherapy and surgery for early-stage non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356.
    >> Share

  123. SHUJA M, Owen D
    What if Perioperative Therapy for Non-Small Cell Lung Cancer Renders Someone Inoperable?
    Int J Radiat Oncol Biol Phys. 2024;118:587.
    >> Share

  124. FARLEY A, Nelson B
    Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung Cancer: Queen's Gambit or CheckMate?
    Int J Radiat Oncol Biol Phys. 2024;118:585-586.
    >> Share

    February 2024
  125. BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
    A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
    >> Share

  126. WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
    A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
    >> Share

  127. HAN C, Qiu J, Bai L, Liu T, et al
    Pneumonitis risk after chemoradiotherapy with and without immunotherapy in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024 Feb 13:S0360-3016(24)00298.
    >> Share

  128. KIM H, Lee E, Cho H, Kim E, et al
    Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity.
    Int J Radiat Oncol Biol Phys. 2024;118:498-511.
    >> Share

    January 2024
  129. WANG J, Liu Y, Wu D, Tian C, et al
    OTUB1 targets CHK1 for deubiquitinating and stabilizing to facilitate lung cancer progression and radioresistance.
    Int J Radiat Oncol Biol Phys. 2024 Jan 22:S0360-3016(24)00246.
    >> Share

  130. TRAN PT, Mouw KW
    SABR Today . . . and Tomorrow?
    Int J Radiat Oncol Biol Phys. 2024;118:11.
    >> Share

  131. WRIGHT JL, Bazan JG
    Time to Reconsider the Role of Diagnostic Chest Computed Tomography in Early-Stage Breast Cancer?
    Int J Radiat Oncol Biol Phys. 2024;118:104-106.
    >> Share

  132. CHEN Y, Pahlavian SH, Jacobs P, Neupane T, et al
    Systematic Evaluation of the Impact of Lung Segmentation Methods on 4-Dimensional Computed Tomography Ventilation Imaging Using a Large Patient Database.
    Int J Radiat Oncol Biol Phys. 2024;118:242-252.
    >> Share

    December 2023
  133. BARTOLOMEO V, Cortiula F, Hendriks LEL, De Ruysscher D, et al
    A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Dec 27:S0360-3016(23)08126.
    >> Share

  134. RIMNER A, Gelblum DY, Wu AJ, Shepherd AF, et al
    Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer - A Phase I Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08252.
    >> Share

  135. RAN X, Wu BX, Shi M, Song L, et al
    CRISPR screen of druggable targets in small cell lung cancer identified ATM inhibitor (AZD1390) as a radiosensitizer.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08245.
    >> Share

  136. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    >> Share

  137. BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al
    Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase Ib Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166.
    >> Share

  138. DUDAS D, Saghad PG, Dilling TJ, Perez BA, et al
    Deep Learning-Guided Dosimetry for Mitigating Local Failure of Non-Small Cell Lung Cancer Patients Receiving SBRT.
    Int J Radiat Oncol Biol Phys. 2023 Dec 4:S0360-3016(23)08185.
    >> Share

  139. SAFAVI AH, Palma DA, Giuliani ME
    Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?
    Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
    >> Share

  140. SIVA S, Staehler M
    The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
    Int J Radiat Oncol Biol Phys. 2023;117:1047.
    >> Share

  141. AHN J, Yeghiaian-Alvandi R, Hegi-Johnson F, Browne LH, et al
    SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life.
    Int J Radiat Oncol Biol Phys. 2023;117:1213-1221.
    >> Share

  142. LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al
    Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
    >> Share

  143. LEE SH, Geng H, Arnold J, Caruana R, et al
    Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
    Int J Radiat Oncol Biol Phys. 2023;117:1270-1286.
    >> Share

    November 2023
  144. MA J, Li Y, Yu H, Zhang J, et al
    The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Non-Small Cell Lung Cancer Patients Receiving Lung Radiotherapy and Immunotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08165.
    >> Share

  145. VALDES G, Scholey J, Nano T, Gennatas ED, et al
    Predicting the impact of proton beam therapy technology on pulmonary toxicities for locally advanced lung cancer patients enrolled on the Proton Collaborative Group prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2023 Nov 22:S0360-3016(23)08154.
    >> Share

  146. RAMESH S, Cifci A, Javeri S, Minne R, et al
    MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08139.
    >> Share

  147. RITTER AR, Miller ED
    No Regrets About SABR for NETs.
    Int J Radiat Oncol Biol Phys. 2023;117:786.
    >> Share

  148. BUCKNELL NW, Hardcastle N, Woon B, Selbie L, et al
    The HI-FIVE Trial: A Prospective Trial Using 4-Dimensional (68)Ga Ventilation-Perfusion Positron Emission Tomography-Computed Tomography for Functional Lung Avoidance in Locally Advanced Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:887-892.
    >> Share

  149. OMIDI A, Weiss E, Rosu-Bubulac M, Thomas G, et al
    Quantitative analysis of radiotherapy-induced cardiac and aortic sequelae in lung cancer patients via magnetic resonance imaging: A pilot study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08045.
    >> Share

  150. KUIPERS ME, van Doorn-Wink KCJ, Hiemstra PS, Slats AM, et al
    Predicting radiation-induced lung injury in lung cancer patients - challenges and opportunities: Predicting radiation-induced lung injury.
    Int J Radiat Oncol Biol Phys. 2023 Nov 2:S0360-3016(23)08049.
    >> Share

  151. HEGI-JOHNSON F, Rudd SE, Wichmann CW, Akhurst T, et al
    PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
    Int J Radiat Oncol Biol Phys. 2023;117:675-682.
    >> Share

    October 2023
  152. GAUDREAULT M, Bucknell N, Woon B, Kron T, et al
    Dose-response relationship between radiotherapy and loss of lung perfusion comparing positron emission tomography and dual-energy computed tomography in non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08047.
    >> Share

  153. FRIEDES C, Iocolano M, Lee SH, Li B, et al
    Patterns of Failure, Low Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors: Patterns of Failure for after PACIFIC.
    Int J Radiat Oncol Biol Phys. 2023 Oct 20:S0360-3016(23)08010.
    >> Share

  154. EDWARDS DM, Sankar K, Alseri A, Jiang R, et al
    Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971.
    >> Share

    September 2023
  155. LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al
    Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929.
    >> Share

  156. MENG Y, Sun H, Wang S, Yang H, et al
    Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023 Sep 14:S0360-3016(23)07917.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016